Dexmedetomidine Effectively Sedates Asian Elephants (Elephas maximus)

Simple Summary Sedation in standing procedures is commonly performed in elephants. To successfully and safely initiate standing in elephants, chemical restraint drugs should provide sufficient sedation with minimal complications (i.e., recumbency, significant physiologic alterations, and prolonged recovery). This study investigated the sedative effects of dexmedetomidine in Asian elephants. Results suggest dexmedetomidine 1-2 mu g/kg provides effective sedation. However, we suggest a single intramuscular dexmedetomidine injection of 2 mu g/kg for approximately 70 min of sedation. This is the first study to demonstrate dexmedetomidine use in Asian elephants. This study investigated the sedative effects of dexmedetomidine in Asian elephants. We hypothesized that 2 mu g/kg dexmedetomidine would provide sufficient standing sedation. A crossover design study was performed in three Asian elephants. Each elephant was assigned to 1 of 3 treatment groups-1 (D1), 1.5 (D1.5) or 2 (D2) mu g/kg dexmedetomidine (intramuscular injection, IM) with a two-week 'washout period' between doses. Elephants were monitored for 120 min. At 120 min (Ta), atipamezole was administered IM. Sedation and responsiveness scores were evaluated. Physiological parameters (pulse rate, respiratory rate, and %SpO(2)) and clinical observations were monitored during the study and for 3 days post drug administration. D2 provided the longest sedation (approximately 70 min), compared to D1 and D1.5. After Ta, each elephant's sedative stage lessened within 10-15 min without complications. No significant abnormal clinical observations were noted throughout and during the 3-days post study period. These data suggest that a single 2 mu g/kg IM dexmedetomidine injection provides sufficient standing sedation for approximately 70 min in Asian elephants.